Showing results (451-460 of 666) with videos related to
Sort By:
Pageof 67
Current Problems in Cancer|July 5, 2025
Roles for epigenetic and other biomarkers in upper tract urothelial carcinoma diagnosis and surveillanceGabriele Ricciardi, Pietro Tralongo, Vincenzo Fiorentino, et al.Current Problems in Cancer|December 17, 2025
Electronic symptom monitoring improves chemotherapy dose intensity in neoadjuvant chemotherapy for breast cancerYuki Takei, Atsufumi Nomoto, Mizuki Kawashima, et al.Current Problems in Cancer|December 28, 2024
Revolutionizing lung cancer treatment: Introducing PROTAC therapy as a novel paradigm in targeted therapeuticsAtharva Mahajan, Gauri Panzade, Tiyasa Bhuniya, et al.Current Problems in Cancer|December 21, 2024
Ophthalmologic toxicities of antineoplastic agents in genitourinary cancers: Mechanisms, management, and clinical implicationsAditya Mahadevan, Omid Yazdanpanah, Vivek Patel, et al.Current Problems in Cancer|January 24, 2025
Efficacy and safety of gene therapy approaches for malignant gliomas: A systematic review and meta-analysis: ConNRNRNRNR22.5NRNR1011.413.511.9NRNRNRElnaz Amanzadeh Jajin, Saeed Oraee-Yazdani, Alireza Zali, et al.Current Problems in Cancer|July 5, 2024
Menin signaling and therapeutic targeting in breast cancerPeng Liu, Chaowen Shi, Lipeng Qiu, et al.Current Problems in Cancer|July 3, 2024
Capivasertib in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative advanced breast cancerZaheer Qureshi, Faryal Altaf, Mikail Khanzada, et al.Current Problems in Cancer|June 30, 2024
The predictive value of hematological inflammatory markers for severe oral mucositis in patients with nasopharyngeal carcinoma during intensity-modulated radiation therapy: A retrospective cohort studyXiaoxian Huang, Xinling Qin, Weimei Huang, et al.Current Problems in Cancer|November 18, 2023
Using machine learning algorithms to predict the prognosis of advanced nasopharyngeal carcinoma after intensity-modulated radiotherapyDan Hu, Ying Wang, Genxin Ji, et al.Current Problems in Cancer|March 28, 2024
Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records dataSikander Ailawadhi, Mu Cheng, Dasha Cherepanov, et al.Pageof 67